BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30104738)

  • 1. Endogenous HIF2A reporter systems for high-throughput functional screening.
    Zaini MN; Patel SA; Syafruddin SE; Rodrigues P; Vanharanta S
    Sci Rep; 2018 Aug; 8(1):12063. PubMed ID: 30104738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
    Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
    BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.
    Syafruddin SE; Rodrigues P; Vojtasova E; Patel SA; Zaini MN; Burge J; Warren AY; Stewart GD; Eisen T; Bihary D; Samarajiwa SA; Vanharanta S
    Nat Commun; 2019 Mar; 10(1):1152. PubMed ID: 30858363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis.
    Zou Y; Palte MJ; Deik AA; Li H; Eaton JK; Wang W; Tseng YY; Deasy R; Kost-Alimova M; Dančík V; Leshchiner ES; Viswanathan VS; Signoretti S; Choueiri TK; Boehm JS; Wagner BK; Doench JG; Clish CB; Clemons PA; Schreiber SL
    Nat Commun; 2019 Apr; 10(1):1617. PubMed ID: 30962421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a DGKθ Endogenous Promoter Luciferase Reporter HepG2 Cell Line for Studying the Transcriptional Regulation of DGKθ Gene.
    Shan L; Wang D; Mao Q; Xia H
    Appl Biochem Biotechnol; 2019 Apr; 187(4):1344-1355. PubMed ID: 30229432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a novel HEK293 luciferase reporter cell line by CRISPR/Cas9-mediated site-specific integration in the genome to explore the transcriptional regulation of the PGRN gene.
    Li Y; Li S; Li Y; Xia H; Mao Q
    Bioengineered; 2019 Dec; 10(1):98-107. PubMed ID: 31023186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intron with transgenic marker (InTraM) facilitates high-throughput screening of endogenous gene reporter lines.
    Collins RT; Coxam B; Fechner I; Unterweger I; Szymborska A; Meier K; Gerhardt H
    Genesis; 2020 Nov; 58(10-11):e23391. PubMed ID: 32783355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
    Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
    Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput genetic screens using CRISPR-Cas9 system.
    Kweon J; Kim Y
    Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput single-cell chromatin accessibility CRISPR screens enable unbiased identification of regulatory networks in cancer.
    Pierce SE; Granja JM; Greenleaf WJ
    Nat Commun; 2021 May; 12(1):2969. PubMed ID: 34016988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a HEK293 cell line by CRISPR/Cas9-mediated luciferase knock-in to study transcriptional regulation of the human SREBP1 gene.
    Li Z; Zhao J; Muhammad N; Wang D; Mao Q; Xia H
    Biotechnol Lett; 2018 Dec; 40(11-12):1495-1506. PubMed ID: 30232659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous Locus Reporter Assays.
    Liu Y; Hermes J; Li J; Tudor M
    Methods Mol Biol; 2018; 1755():163-177. PubMed ID: 29671270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Edited Cell Lines for High-Throughput Screening.
    Dranchak P; Moran JJ; MacArthur R; Lopez-Anido C; Inglese J; Svaren J
    Methods Mol Biol; 2018; 1755():1-17. PubMed ID: 29671259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large scale control and programming of gene expression using CRISPR.
    Deyell M; Ameta S; Nghe P
    Semin Cell Dev Biol; 2019 Dec; 96():124-132. PubMed ID: 31181342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Genome-Editing Tools to Develop a Novel In Situ Coincidence Reporter Assay for Screening ATAD3A Transcriptional Inhibitors.
    Lang L; Teng Y
    Methods Mol Biol; 2020; 2138():159-166. PubMed ID: 32219745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Sci Rep; 2016 Jan; 6():18759. PubMed ID: 26729410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology arms of targeting vectors for gene insertions and CRISPR/Cas9 technology: size does not matter; quality control of targeted clones does.
    Petrezselyova S; Kinsky S; Truban D; Sedlacek R; Burtscher I; Lickert H
    Cell Mol Biol Lett; 2015 Dec; 20(5):773-87. PubMed ID: 26540224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Transcriptional Regulation in Bone Cells.
    Jin H; Sophocleous A; Azfer A; Ralston SH
    Methods Mol Biol; 2019; 1914():145-167. PubMed ID: 30729464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma.
    Liu W; Chen H; Wong N; Haynes W; Baker CM; Wang X
    Cancer Lett; 2017 May; 394():65-75. PubMed ID: 28257806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights to transcriptional networks by using high throughput RNAi strategies.
    Mattila J; Puig O
    Brief Funct Genomics; 2010 Jan; 9(1):43-52. PubMed ID: 19952073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.